MedPath

UROCIT-K

Urocit ®-K (Potassium Citrate) Extended Release Tablets for Oral Use These highlights do not include all the information needed to use Urocit -K safely and effectively. See full prescribing information for Urocit -K. Initial U.S. Approval: 1985

Approved
Approval ID

72cdea1b-2240-41db-987d-86d5c6aaa978

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 8, 2024

Manufacturers
FDA

Mission Pharmacal Company

DUNS: 008117095

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

potassium citrate

PRODUCT DETAILS

NDC Product Code0178-0600
Application NumberNDA019071
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateJanuary 8, 2024
Generic Namepotassium citrate

INGREDIENTS (3)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
POTASSIUM CITRATEActive
Quantity: 5 meq in 1 1
Code: EE90ONI6FF
Classification: ACTIB

potassium citrate

PRODUCT DETAILS

NDC Product Code0178-0610
Application NumberNDA019071
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateJanuary 8, 2024
Generic Namepotassium citrate

INGREDIENTS (3)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
POTASSIUM CITRATEActive
Quantity: 10 meq in 1 1
Code: EE90ONI6FF
Classification: ACTIB

potassium citrate

PRODUCT DETAILS

NDC Product Code0178-0615
Application NumberNDA019071
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateJanuary 8, 2024
Generic Namepotassium citrate

INGREDIENTS (3)

CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POTASSIUM CITRATEActive
Quantity: 15 meq in 1 1
Code: EE90ONI6FF
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath
UROCIT-K - FDA Approval | MedPath